GlassScriptPhysician profile
Rachel Falkner
NPI 1457790214
$2,086.93
in general payments reported to CMS, 2019-2025
21 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.47 · 2022: $279 · 2023: $854 · 2024: $801 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.71 |
| Education | $115.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $273.70 | 2022-2024 | Rinvoq, Botox |
| Organogenesis INC. | $265.84 | 2023-2025 | Puraply, Affinity, Via Matrix |
| Novartis Pharmaceuticals Corporation | $202.72 | 2022-2024 | |
| Janssen Biotech, INC. | $195.47 | 2023-2025 | Tremfya, Simponi, Stelara |
| Pfizer INC. | $186.61 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $153.74 | 2022-2025 | Dupixent |
| Ucb, INC. | $133.93 | 2023-2024 | Bimzelx, Cimzia |
| Lilly USA, LLC | $110.38 | 2023-2024 | Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $100.17 | 2023-2024 | Ilumya |
| Incyte Corporation | $92.59 | 2022-2023 | Opzelura |
| Genzyme Corporation | $72.37 | 2020-2023 | |
| Dermavant Sciences, INC. | $61.49 | 2023-2024 | Vtama |
| Amgen INC. | $55.56 | 2022-2023 | Otezla |
| Leo Pharma INC. | $53.13 | 2023-2024 | Adbry |
| Smith+Nephew, INC. | $28.59 | 2024 | Grafix Pl |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.68 | 2022 | |
| Biofrontera INC. | $20.68 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.74 | 2022 | |
| Galderma Laboratories, L.P. | $16.40 | 2024 | |
| Journey Medical Corporation | $12.20 | 2022 | |
| Mayne Pharma Commercial LLC | $6.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Falkner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.